Aphria Inc (NYSE:APHA) Receives $14.75 Average PT from Brokerages

Aphria Inc (NYSE:APHA) has been assigned an average recommendation of “Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $13.63.

A number of research firms recently weighed in on APHA. Jefferies Financial Group began coverage on shares of Aphria in a research note on Friday, May 24th. They issued a “buy” rating and a $11.00 price objective for the company. Clarus Securities began coverage on shares of Aphria in a research note on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price objective for the company. Zacks Investment Research upgraded shares of Aphria from a “hold” rating to a “buy” rating and set a $8.00 price objective for the company in a research note on Wednesday, August 7th. CIBC lowered shares of Aphria from a “neutral” rating to a “sector underperform” rating in a research report on Friday, July 26th. Finally, ValuEngine upgraded shares of Aphria from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st.

A number of institutional investors and hedge funds have recently made changes to their positions in APHA. Synovus Financial Corp grew its holdings in shares of Aphria by 56.9% during the second quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock valued at $39,000 after buying an additional 2,000 shares during the last quarter. Advisory Services Network LLC grew its holdings in shares of Aphria by 45.3% during the first quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock valued at $52,000 after buying an additional 1,755 shares during the last quarter. Liberty Wealth Management LLC purchased a new stake in shares of Aphria during the second quarter valued at approximately $44,000. Truvestments Capital LLC purchased a new stake in shares of Aphria during the first quarter valued at approximately $61,000. Finally, Capital Investment Advisory Services LLC grew its holdings in shares of Aphria by 2,233.3% during the second quarter. Capital Investment Advisory Services LLC now owns 7,000 shares of the company’s stock valued at $43,000 after buying an additional 6,700 shares during the last quarter. Institutional investors and hedge funds own 8.54% of the company’s stock.

Aphria stock traded up $0.22 during mid-day trading on Monday, reaching $6.56. The company’s stock had a trading volume of 3,697,486 shares, compared to its average volume of 6,751,429. Aphria has a 12-month low of $3.75 and a 12-month high of $16.86. The firm has a market cap of $1.65 billion, a P/E ratio of -59.64 and a beta of 3.07. The stock has a fifty day moving average of $6.49.

Aphria (NYSE:APHA) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.10. The business had revenue of $128.60 million during the quarter, compared to analysts’ expectations of $99.26 million. The company’s revenue for the quarter was up 971.7% on a year-over-year basis. As a group, sell-side analysts forecast that Aphria will post 0.06 earnings per share for the current fiscal year.

Aphria Company Profile

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Featured Article: What is the Dividend Aristocrat Index?

Analyst Recommendations for Aphria (NYSE:APHA)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.